BR(BR)
BR
Q4 2026 EPS Estimate
$1.37
Nov 3, 2026 · Reports before open
Revenue Estimate
$1.65B
FY2027E EPS$10.56
FY2028E EPS$11.56
Analyst Sentiment
Wall St. Consensus
Buy23 analysts·High coverage
66
Score
15 Buy (65%)8 Hold (35%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1565%
Hold
835%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$176.00
+3.6%
Consensus
$197.00
+16.0%
Bull
$225.00
+32.4%
12-Month Target Range23 analysts
$176.00$197.00$225.00
Current $169.88Consensus
Current Price
$169.88
Upside to Consensus
$27.12
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+5.83%
EPS+10.53%
FY2028
Rev+4.76%
EPS+9.52%
FY2029
Rev+4.43%
EPS+9.46%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $7.86B | $8.24B | $8.60B | $9.04B | $9.45B |
| Low | $7.82B | $8.15B | $8.54B | $8.94B | $9.34B |
| High | $7.91B | $8.33B | $8.73B | $9.12B | $9.53B |
| EBITDA Avg | $1.71B | $1.80B | $1.88B | $1.97B | $2.06B |
| Low | $1.71B | $1.78B | $1.86B | $1.95B | $2.04B |
| High | $1.73B | $1.82B | $1.90B | $1.99B | $2.08B |
| EBIT Avg | $1.25B | $1.31B | $1.36B | $1.43B | $1.50B |
| Low | $1.24B | $1.29B | $1.35B | $1.42B | $1.48B |
| High | $1.26B | $1.32B | $1.38B | $1.45B | $1.51B |
| Net Income Avg | $1.22B | $1.32B | $1.49B | $1.64B | $1.81B |
| Low | $1.22B | $1.31B | $1.44B | $1.62B | $1.78B |
| High | $1.24B | $1.39B | $1.55B | $1.66B | $1.83B |
| EPS Avg | $10.56 | $11.56 | $12.66 | $14.00 | $15.45 |
| Low | $10.38 | $11.16 | $12.27 | $13.80 | $15.23 |
| High | $10.63 | $11.83 | $13.20 | $14.16 | $15.63 |
| Analysts (Rev / EPS) | 6 / 7 | 7 / 7 | 4 / 3 | 2 / 1 | 1 / 2 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.65B | $1.79B | $2.07B | $2.35B | $1.74B | $1.89B | $2.18B | $2.47B |
| Low | $1.63B | $1.77B | $2.05B | $2.33B | $1.72B | $1.87B | $2.16B | $2.45B |
| High | $1.66B | $1.81B | $2.09B | $2.37B | $1.75B | $1.91B | $2.20B | $2.49B |
| EBITDA Avg | $359M | $390M | $452M | $512M | $379M | $412M | $475M | $539M |
| Low | $356M | $386M | $448M | $508M | $375M | $408M | $471M | $534M |
| High | $362M | $395M | $456M | $517M | $382M | $416M | $479M | $544M |
| EBIT Avg | $261M | $284M | $329M | $373M | $275M | $300M | $346M | $392M |
| Low | $259M | $281M | $326M | $369M | $273M | $297M | $343M | $389M |
| High | $263M | $287M | $331M | $376M | $278M | $302M | $349M | $396M |
| Net Income Avg | $159M | $207M | $345M | $510M | $188M | $228M | $376M | $549M |
| Low | $147M | $205M | $341M | $504M | $186M | $225M | $371M | $542M |
| High | $168M | $210M | $349M | $516M | $190M | $231M | $380M | $555M |
| EPS Avg | $1.37 | $1.79 | $2.99 | $4.42 | $1.63 | $1.97 | $3.25 | $4.75 |
| Low | $1.27 | $1.77 | $2.95 | $4.36 | $1.61 | $1.95 | $3.21 | $4.69 |
| High | $1.45 | $1.81 | $3.02 | $4.47 | $1.65 | $2.00 | $3.29 | $4.80 |
| Analysts (Rev / EPS) | 5 / 5 | 5 / 5 | 4 / 3 | 4 / 3 | 4 / 3 | 4 / 3 | 3 / 4 | 3 / 4 |